168 related articles for article (PubMed ID: 27248136)
1. Metformin ameliorates podocyte damage by restoring renal tissue nephrin expression in type 2 diabetic rats.
Zhai L; Gu J; Yang D; Hu W; Wang W; Ye S
J Diabetes; 2017 May; 9(5):510-517. PubMed ID: 27248136
[TBL] [Abstract][Full Text] [Related]
2. Saxagliptin attenuates glomerular podocyte injury by increasing the expression of renal nephrin and podocin in type 2 diabetic rats.
Hu Y; Ye S; Xing Y; Lv L; Hu W; Zhou W
Acta Diabetol; 2020 Mar; 57(3):279-286. PubMed ID: 31535208
[TBL] [Abstract][Full Text] [Related]
3. Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats.
Zhai L; Gu J; Yang D; Wang W; Ye S
J Diabetes Res; 2015; 2015():231825. PubMed ID: 26075281
[TBL] [Abstract][Full Text] [Related]
4. [Protective effects of metformin on glomerular podocytes of type 2 diabetes model rats].
Zhai L; Ye S; Gu J; Yang D; Hu W
Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(40):3313-6. PubMed ID: 26815356
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats.
Peng T; Chang X; Wang J; Zhen J; Yang X; Hu Z
Mol Med Rep; 2017 May; 15(5):3172-3178. PubMed ID: 28339051
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
Lee EY; Kim GT; Hyun M; Kim S; Seok S; Choi R; Lee MY; Chung CH
Nephrol Dial Transplant; 2012 Nov; 27(11):4069-79. PubMed ID: 22892126
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
8. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
9. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
[TBL] [Abstract][Full Text] [Related]
10. [Effect of bone morphogenic protein 7 on nephrin expression and distribution in diabetic rat kidneys].
Xiao HQ; Shi W; Zhang Y; Liang YZ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):671-5. PubMed ID: 19403392
[TBL] [Abstract][Full Text] [Related]
11. FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats.
Qi XM; Wang J; Xu XX; Li YY; Wu YG
Inflamm Res; 2016 Feb; 65(2):103-14. PubMed ID: 26566632
[TBL] [Abstract][Full Text] [Related]
12. Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin.
Kim J; Shon E; Kim CS; Kim JS
Exp Diabetes Res; 2012; 2012():210821. PubMed ID: 23056035
[TBL] [Abstract][Full Text] [Related]
13. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
15. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.
Han J; Zhang Y; Shi X; Peng Z; Xing Y; Pang X
J Tradit Chin Med; 2021 Feb; 41(1):125-132. PubMed ID: 33522205
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes.
Bai X; Li X; Tian J; Zhou Z
PLoS One; 2014; 9(4):e96117. PubMed ID: 24759991
[TBL] [Abstract][Full Text] [Related]
18. Phloretin ameliorates diabetic nephropathy by inhibiting nephrin and podocin reduction through a non-hypoglycemic effect.
Liu J; Sun M; Xia Y; Cui X; Jiang J
Food Funct; 2022 Jun; 13(12):6613-6622. PubMed ID: 35622066
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin I2 Receptor Agonism Preserves β-Cell Function and Attenuates Albuminuria Through Nephrin-Dependent Mechanisms.
Batchu SN; Majumder S; Bowskill BB; White KE; Advani SL; Brijmohan AS; Liu Y; Thai K; Azizi PM; Lee WL; Advani A
Diabetes; 2016 May; 65(5):1398-409. PubMed ID: 26868296
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide protects from renal damage via Akt-mTOR pathway in rats with diabetic kidney disease.
Liao TT; Zhao LB; Liu H; He RL; Wang YQ; Li J
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):117-125. PubMed ID: 31389583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
